Log In
BCIQ
Print this Print this
 

VXM04

  Manage Alerts
Collapse Summary General Information
Company Vaximm AG
DescriptionImmunotherapy that targets a tumor-associated antigen expressed in gastrointestinal cancers
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today